BUY MBP FULURSTRANT FULVETRAZ 250MG VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Fulvestrant is a hormonal anticancer medicine used mainly to treat hormone receptor?positive breast cancer, particularly in postmenopausal women. It is commonly prescribed for advanced or metastatic breast cancer that has progressed despite previous hormone therapy. Fulvestrant works by targeting and blocking the effects of oestrogen, a hormone that can stimulate the growth of certain breast cancer cells.

Fulvestrant belongs to a class of medicines known as selective estrogen receptor degraders. Unlike some other hormonal therapies that only block estrogen activity, fulvestrant binds directly to estrogen receptors on cancer cells and causes them to break down. This reduces both the number and activity of estrogen receptors, effectively stopping estrogen from stimulating cancer cell growth. Because of this mechanism, fulvestrant is sometimes described as a ?pure anti-estrogen.?

Fulvestrant is given as an intramuscular injection, usually into the muscle of the buttock. It is not taken by mouth. The usual dosing schedule involves two injections given on day 1, followed by additional doses on day 15 and day 29, and then once monthly thereafter. The injections are given slowly by a healthcare professional, as the volume can be large and may cause discomfort if administered too quickly.

Fulvestrant is often used alone or in combination with other cancer treatments such as CDK4/6 inhibitors, depending on the type and stage of breast cancer. Combination therapy may improve effectiveness and delay disease progression. The choice of treatment depends on factors such as previous therapies, menopausal status, and overall health.

Common side effects of fulvestrant include pain or soreness at the injection site, hot flushes, fatigue, nausea, headache, joint or muscle pain, and mild gastrointestinal discomfort. Some patients may also experience weakness or mild mood changes. These side effects are usually manageable and tend to improve over time.

Less common but more serious side effects may include liver function abnormalities, increased risk of bleeding (especially in patients taking blood thinners), and allergic reactions. Liver function tests are often monitored during treatment to ensure safety. Any symptoms such as yellowing of the skin or eyes, severe fatigue, or unexplained bruising should be reported promptly.

Fulvestrant may cause temporary suppression of ovarian function in premenopausal women and is usually used only in postmenopausal patients unless combined with medicines that suppress ovarian activity. It is not recommended during pregnancy, as it can harm an unborn baby. Effective contraception should be used during treatment and for a period after the final dose. Breastfeeding is also not recommended during treatment.

Fulvestrant does not cause hair loss in most patients, and many people are able to maintain daily activities while receiving treatment. However, individual responses vary, and regular follow-up is important to assess effectiveness and manage side effects.

Patients receiving fulvestrant should attend regular appointments for physical examination, imaging when required, and blood tests to monitor liver function and overall health. It is important to report any new or worsening symptoms to the healthcare team promptly.

Fulvestrant plays an important role in the management of hormone receptor?positive advanced breast cancer. By directly targeting estrogen receptors, it helps slow disease progression, improve symptom control, and extend quality of life when used appropriately and under specialist supervision.